Lotus 1-2-3

From WikiMD's Wellness Encyclopedia

Lotus 1-2-3 for DOS - Release 2.3 - User's Guide.jpg
1-2-3 Floppy Disk Set.jpg
Lotus 1-2-3 on PC-98 DOS chart.jpg
Lotus123 Macro.JPG
Lotus 1-2-3 on PC-98 DOS spreadsheet.jpg

Spreadsheet software


Lotus 1-2-3

  [[File:Script error: No such module "InfoboxImage".|frameless|alt=]]


Other names
Original author(s)
Developer(s)Lotus Software
Initial release1983
Repository
  • {{URL|example.com|optional display text}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Written in
Middleware
Engine
    Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).



    Lotus 1-2-3 is a spreadsheet program developed by Lotus Software (later part of IBM). It was the first killer application of the IBM PC, and contributed significantly to the success of the IBM PC in the business world. Lotus 1-2-3 was released on January 26, 1983.

    History[edit | edit source]

    Lotus 1-2-3 was developed by Mitch Kapor and Jonathan Sachs. The name "1-2-3" refers to the integration of three main capabilities: spreadsheet calculations, database functionality, and graphical charting. The software quickly became popular due to its speed and efficiency, which were superior to other spreadsheet programs available at the time, such as VisiCalc.

    Features[edit | edit source]

    Lotus 1-2-3 introduced several features that were innovative for its time:

    • Integrated Graphing: Users could create graphical charts directly from the spreadsheet data.
    • Database Functions: It included basic database management capabilities, allowing users to sort and query data.
    • Macros: Users could automate repetitive tasks by recording macros.
    • Cell Addressing: It used the A1 notation for cell addressing, which became a standard in spreadsheet software.

    Versions[edit | edit source]

    Lotus 1-2-3 was initially released for MS-DOS, but later versions were developed for Microsoft Windows and OS/2. The software saw numerous updates and versions, with the final version being 9.8, released in 2002. Despite its early success, Lotus 1-2-3 eventually lost market share to Microsoft Excel.

    Decline and Discontinuation[edit | edit source]

    The rise of Microsoft Excel in the 1990s, which offered more advanced features and better integration with other Microsoft Office applications, led to the decline of Lotus 1-2-3. IBM, which acquired Lotus Software in 1995, officially discontinued Lotus 1-2-3 in 2013.

    Legacy[edit | edit source]

    Lotus 1-2-3 played a crucial role in the adoption of personal computers in business environments. It set the standard for spreadsheet software and influenced the development of future applications. The program's success demonstrated the potential of software to drive hardware sales, a concept that continues to be relevant in the technology industry.

    See also[edit | edit source]

    References[edit | edit source]

    External links[edit | edit source]

    WikiMD
    Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

    Search WikiMD

    Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
    Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
    Advertise on WikiMD

    WikiMD's Wellness Encyclopedia

    Let Food Be Thy Medicine
    Medicine Thy Food - Hippocrates

    Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
    Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

    Contributors: Prab R. Tumpati, MD